Drug development is a notoriously slow, complex and costly process, with over 90% of drug candidates failing before reaching the market. A major cause of this inefficiency is the reliance on ...
SARASOTA, Fla. and HUNTSVILLE, Ala., June 11, 2025 /PRNewswire/ -- World Precision Instruments (WPI), a global leader in transepithelial electrical resistance (TEER) instrumentation, and SynVivo Inc., ...
Organ-on-a-chip technology has rapidly gained prominence and relevance at the interface between biology and engineering due to its burgeoning potential to revolutionise biomedical research and ...
US-based contract research organisation (CRO) PhenoVista Biosciences has entered a collaboration with NETRI, the France-based manufacturer of microfluidic devices for high-throughput screening, to ...
The partnership leverages the Hesperos organ-on-a-chip platform in the preclinical development of Psilera’s lead compound targeting the progressive neurological disorder for which treatment options ...
BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug ...
China recently released a standard for skin-on-a-chip technology, the country’s first national standard in the field of organ-on-a-chip technology, which marks a significant step forward for China in ...
Beyond Emulate, CN Bio Innovations has also forged a Cooperative Research and Development Agreement (CRADA) with the FDA, exploring advanced hepatic models through its PhysioMimix platform. In one ...
Blood vessels are like big-city highways; full of curves, branches, merges and congestion. Yet for years, lab models replicated vessels like straight, simple roads. To better capture the complex ...
(MENAFN- GlobeNewsWire - Nasdaq) Join the Lab-on-a-Chip, Microfluidics, Organoids & Organ-on-a-Chip Asia 2025 Conference on October 6-7 at the Nikko Narita, Tokyo-Narita Airport. Network with global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results